Provider
QP48-23 Update for New to Market Medical Drugs: delandistrogene moxeparvovec and epcoritamab
Program effective Date: Jun 14, 2023
Program effective Date: Jun 14, 2023
Program effective Date: Jun 14, 2023
Program effective Date: Jun 14, 2023
Program effective Date: Jun 14, 2023
Program effective Date: Jun 14, 2023
Program effective Date: Jun 01, 2023
Program effective Date: Jun 01, 2023
Program effective Date: Jun 01, 2023
Program effective Date: Jun 01, 2023
Program effective Date: Jun 01, 2023